by Annabel Sedgwick
Share
by Annabel Sedgwick
Share
ACS Motion Control – part of the Physik Instrumente (PI) Group – has launched the first in a new line of Economical Control Module (ECM) products. The ECMsm is a compact, all-in-one, 2- or 4-axis motion controller with internal drives. Designed for OEMs with cost-sensitive motion control applications, it provides up to 5/10A per axis with a 12-48 VDC drive supply.
Its industrial packaging and comprehensive software tools minimize integration efforts to reduce time to market.
“With its compact, all-in-one configuration, the ECMsm is ideal for small footprint equipment in biomedical, semiconductor and other high-tech industries,” said Jason Goerges, ACS Motion Control USA General Manager and Vice President of Global Marketing. “As OEM machine builders expand their lower-cost, lower-footprint offerings, there is a clear requirement for a cost-optimized motion controller and drive platform using the same software language and tools as high-end motion control platforms. The ECMsm and future Economical Control Module products will address that need, complementing our flagship SPiiPlus product platform.”
For more details, visit https://acsmotioncontrol.com/products/ecm-motion-controllers-with-integrated-servo-drives/ecmsm/ or contact [email protected].
Media Contact: Katy Evans [email protected]
Technical Contact: Ross Tomlin [email protected]
Microban® International – the global leader in antimicrobial additives and odor control solutions – has released a statement discrediting unwarranted claims about the safety and efficacy of antimicrobial technologies. This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning. Making a clear distinction between public health and non-public health claims, Microban has explained the advantages of incorporating its antimicrobial additives into
Anion dysregulation is seen in numerous diseases, from cystic fibrosis and chronic pain, to autism and cancer. Researchers at the University of Dallas are investigating anion transport in vivo, developing novel tools to help analyze the effects of both normal and aberrant anion regulation at the molecular level, and are using INTEGRA’s PIPETBOY acu 2 to streamline their cell
June Medical is one of 48 organisations to be recognised for their excellence in innovation in this year’s Queen’s Awards for Enterprise. Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country – rewarding only the most outstanding achievements – with winning businesses able to use the esteemed
A report from the International Agency for Research on Cancer1 recently classified TiO2 as ‘possibly carcinogenic to humans’ by inhalation and similarly, the European Chemicals Agency2 recommended TiO2 be classified as a category 2 carcinogen (suspected of causing cancer). In contrast, antimicrobial technologies from Microban International are based on SilverShield®, the first patented antimicrobial solution